Form 4 for ALNY ALNYLAM PHARMACEUTICALS, INC.
Accepted 2024-10-10 00:00:00 ET · period of report 2024-10-08 · accession 0001735276-24-000098 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-10 | 2024-10-08 | ALNY | Garg Pushkal | CMO, EVP Dev, Med Affairs | A - Grant | $0.00 | +96 | 15.7K | +0.6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-08 | A | A | 96 | $0.00 | 15,705 | D | — | — |